Riskpilot← Back to searchSign inGet full accessPM Beta Invest ApS
APSActiveCVR 41419032Åboulevarden 17A, 3.Activities of holding companies · NACE 6421Est. 2020— employees
Revenue 2025
DKK -69K
+150% vs 2024
EBITDA margin
100.0%
-150% vs 2024
Equity ratio
99.9%
Financial strength
Net profit 2025
DKK -3,6M
-230% vs 2024
| Revenue | DKK -69K | +150% |
| EBITDA | DKK -69K | -150% |
| Net profit | DKK -3,6M | -230% |
| Total assets | DKK 105,3M | -3% |
| Equity | DKK 105,1M | -3% |
| Employees | — | — |
Legal name
PM Beta Invest ApS
CVR number
41419032
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
27. maj 2020
Share capital
DKK 60.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller af den samlede direktion.
Company purpose
Selskabets formål er, direkte eller indirekte, at eje kapitalandele i andre selskaber, samt anden
virksomhed, der efter direktionens skøn er forbundet dermed.
Address
Åboulevarden 17A, 3.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | -5 | -6 | -11 | -12 | -28 | -69 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -5 | -6 | -11 | -12 | -28 | -69 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -5 | -6 | -11 | -12 | -28 | -69 |
| Net financials | 0 | 4.355 | 45.713 | 61.565 | -1.068 | -3.549 |
| Profit before tax | -5 | 4.349 | 45.701 | 61.553 | -1.096 | -3.618 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -5 | 4.349 | 45.701 | 61.553 | -1.096 | -3.618 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 3.995 | 10.404 | 48.320 | 109.886 | 108.818 | 105.268 |
| Equity | 3.990 | 10.393 | 48.298 | 109.851 | 108.755 | 105.137 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 | 11 | 23 | 35 | 63 | 131 |
| Total debt | 5 | 11 | 23 | 35 | 63 | 131 |
EBITDA margin
-6880300.0%
This company
15.8%
Market median
-43546303% vs market
20202025
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
20202025
Return on equity
-3.4%
This company
18.4%
Market median
-118% vs market
20202025
Net profit margin
-361778300.0%
This company
8.1%
Market median
-4466398865% vs market
20202025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20202025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2020-05-27 – 2020-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EB Management | Management | 2020 | — | — |
AB Management | Management | 2020 | — | — |
DR Management | Management | 2020 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
MEINCKE ASSETS ApS | Company | 25.0% | 25.0% | 2020 |
Drakon Holding ApS | Company | 25.0% | 25.0% | 2020 |
HOFF INVESTMENTS ApS | Company | 25.0% | 25.0% | 2020 |
Køpke Invest ApS | Company | 10.0% | 10.0% | 2020 |
Rabinovitz Invest ApS | Company | 10.0% | 10.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HOFF INVESTMENTS ApS
PM Beta Invest ApS Board members of PM Beta Invest ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emil Bjørn Meincke | Management | 0 companies |
| Anders Borchsenius Rasmussen | Management | 0 companies |
| Dragan Rajcetic | Management | 0 companies |